Coenzyme Q10 protects Pc12 cells from cisplatin-induced DNA damage and neurotoxicity

NeuroToxicology

Volumn 36, Issue , 2013, Pages 10-16

  Da Silva Machado, Carla ^a   Mendonça, Leonardo Meneghin ^a   Venancio, Vinicius de Paula ^a   Bianchi, Maria Lourdes Pires ^a   Antunes, Lusânia Maria Greggi ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Cis diamminedichloroplatinum II; Genotoxicity; Neuronal cell model; Neuroprotective agent; Ubiquinone

Indexed keywords

CISPLATIN; DOXORUBICIN; MESSENGER RNA; MITOCHONDRIAL DNA; NERVE GROWTH FACTOR; PROTEIN P53; UBIDECARENONE;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CISPLATIN-INDUCED DNA DAMAGE; CONTROLLED STUDY; CYTOKINESIS; CYTOTOXICITY; DRUG INDUCED DISEASE; GENETIC TRANSCRIPTION; MICRONUCLEUS TEST; NERVE FIBER GROWTH; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PC12 CELL; PRIORITY JOURNAL; RAT;

ANALYSIS OF VARIANCE; ANIMALS; ANTINEOPLASTIC AGENTS; CELL DIFFERENTIATION; CISPLATIN; COMET ASSAY; CYTOKINES; DNA DAMAGE; DOSE-RESPONSE RELATIONSHIP, DRUG; GLUTATHIONE; GLUTATHIONE DISULFIDE; NERVE GROWTH FACTOR; PC12 CELLS; RATS; RNA, MESSENGER; TUMOR SUPPRESSOR PROTEIN P53; UBIQUINONE;

EID: 84875264043     PISSN: 0161813X     EISSN: 18729711     Source Type: Journal    
DOI: 10.1016/j.neuro.2013.02.004     Document Type: Article

References (54)

1. Appella E., Anderson C.W. Post-translational modifications and activation of p53 by genotoxic stresses. Eur J Biochem 2001, 268:2764-2772.
2. Argyriou A.A., Chroni E., Koutras A., Iconomou G., Papapetropoulos S., Polychronopoulos P., et al. Preventing paclitaxel-induced peripheral neuropathy: a phase II trial of vitamin E supplementation. J Pain Symptom Manage 2006, 32:237-244.
3. Balakrishnan P., Lee B.J., Oh D.H., Kim J.O., Lee Y.I., Kim D.D., et al. Enhanced oral bioavailability of Coenzyme Q10 by self-emulsifying drug delivery systems. Int J Pharm 2009, 374:66-72.
4. Basu A., Krishnamurthy S. Cellular responses to cisplatin-induced DNA damage. J Nucleic Acids 2010, 1-16.
5. Cavaletti G., Pezzoni G., Pisano C., Oggioni N., Sala F., Zoia C., et al. Cisplatin-induced peripheral neurotoxicity in rats reduces the circulating levels of nerve growth factor. Neurosci Lett 2002, 322:103-106.
6. Chen H.H., Kuo M.T. Role of glutathione in the regulation of Cisplatin resistance in cancer chemotherapy. Met Based Drugs 2010, 1-7.
7. Crane F.L. Biochemical functions of coenzyme Q10. J Am College Nutr 2001, 20:591-598.
8. Dos Santos G.C., Mendonca L.M., Antonucci G.A., Dos Santos A.C., Antunes L.M., Bianchi Mde L. Protective effect of bixin on cisplatin-induced genotoxicity in PC12 cells. Food Chem Toxicol 2012, 50:335-340.
9. Eastmond D.A., Tucker J.D. Identification of aneuploidy-inducing agents using cytokinesis-blocked human lymphocytes and an antikinetochore antibody. Environ Mol Mutagen 1989, 13:34-43.
10. Fenech M. The in vitro micronucleus technique. Mutat Res 2000, 455:81-95.
11. Fenech M. Cytokinesis-block micronucleus cytome assay. Nat Protoc 2007, 2:1084-1104.
12. Fenech M., Kirsch-Volders M., Natarajan A.T., Surralles J., Crott J.W., Parry J., et al. Molecular mechanisms of micronucleus, nucleoplasmic bridge and nuclear bud formation in mammalian and human cells. Mutagenesis 2011, 26:125-132.
13. Ferrante R.J., Andreassen O.A., Dedeoglu A., Ferrante K.L., Jenkins B.G., Hersch S.M., et al. Therapeutic effects of coenzyme Q10 and remacemide in transgenic mouse models of Huntington's disease. J Neurosci 2002, 22:1592-1599.
14. Ford J.M. Regulation of DNA damage recognition and nucleotide excision repair: another role for p53. Mutat Res 2005, 577:195-202.
15. Fouad A.A., Al-Sultan A.I., Refaie S.M., Yacoubi M.T. Coenzyme Q10 treatment ameliorates acute cisplatin nephrotoxicity in mice. Toxicology 2010, 274:49-56.
16. Fu X., Ji R., Dam J. Acute, subacute toxicity and genotoxic effect of Bio-Quinone Q10 in mice and rats. Regul Toxicol Pharmacol 2009, 53:1-5.
17. Godwin A.K., Meister A., O'Dwyer P.J., Huang C.S., Hamilton T.C., Anderson M.E. High resistance to cisplatin in human ovarian cancer cell lines is associated with marked increase of glutathione synthesis. Proc Natl Acad Sci USA 1992, 89:3070-3074.
18. Greenlee H., Shaw J., Lau Y.K., Naini A., Maurer M. Lack of effect of coenzyme Q10 on doxorubicin cytotoxicity in breast cancer cell cultures. Integr Cancer Ther 2012, 11:243-250.
19. Gutierrez-Mariscal F.M., Perez-Martinez P., Delgado-Lista J., Yubero-Serrano E.M., Camargo A., Delgado-Casado N., et al. Mediterranean diet supplemented with coenzyme Q10 induces postprandial changes in p53 in response to oxidative DNA damage in elderly subjects. Age 2012, 34:389-403.
20. Hetman M., Vashishta A., Rempala G. Neurotoxic mechanisms of DNA damage: focus on transcriptional inhibition. J Neurochem 2010, 114:1537-1549.
21. Kelsey N.A., Wilkins H.M., Linseman D.A. Nutraceutical antioxidants as novel neuroprotective agents. Molecules 2010, 15:7792-7814.
22. Kelso G.F., Porteous C.M., Coulter C.V., Hughes G., Porteous W.K., Ledgerwood E.C., et al. Selective targeting of a redox-active ubiquinone to mitochondria within cells: antioxidant and antiapoptotic properties. J Biol Chem 2001, 276:4588-4596.
23. Kirkland D., Pfuhler S., Tweats D., Aardema M., Corvi R., Darroudi F., et al. How to reduce false positive results when undertaking in vitro genotoxicity testing and thus avoid unnecessary follow-up animal tests: report of an ECVAM Workshop. Mutat Res 2007, 628:31-55.
24. Klein R., Brown D., Turnley A.M. Phenoxodiol protects against cisplatin induced neurite toxicity in a PC-12 cell model. BMC Neurosci 2007, 8:61.
25. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001, 25:402-408.
26. Mancuso M., Orsucci D., Volpi L., Calsolaro V., Siciliano G. Coenzyme Q10 in neuromuscular and neurodegenerative disorders. Curr Drug Targets 2010, 11:111-121.
27. Matthews R.T., Yang L., Browne S., Baik M., Beal M.F. Coenzyme Q10 administration increases brain mitochondrial concentrations and exerts neuroprotective effects. Proc Natl Acad Sci USA 1998, 95:8892-8897.
28. McCarthy S., Somayajulu M., Sikorska M., Borowy-Borowski H., Pandey S. Paraquat induces oxidative stress and neuronal cell death; neuroprotection by water-soluble Coenzyme Q10. Toxicol Appl Pharmacol 2004, 201:21-31.
29. Mendonca L.M., da Silva Machado C., Correia Teixeira C.C., Pedro de Freitas L.A., Pires Bianchi Mde L., Greggi Antunes L.M. Curcumin reduces cisplatin-induced neurotoxicity in NGF-differentiated PC12 cells. Neurotoxicology 2013, 34:205-211.
30. Mendonca L.M., Dos Santos G.C., Antonucci G.A., Dos Santos A.C., Bianchi Mde L., Antunes L.M. Evaluation of the cytotoxicity and genotoxicity of curcumin in PC12 cells. Mutat Res 2009, 675:29-34.
31. Migliore L., Molinu S., Naccarati A., Mancuso M., Rocchi A., Siciliano G. Evaluation of cytogenetic and DNA damage in mitochondrial disease patients: effects of coenzyme Q10 therapy. Mutagenesis 2004, 19:43-49.
32. Park I.H., Kim M.K., Kim S.U. Ursodeoxycholic acid prevents apoptosis of mouse sensory neurons induced by cisplatin by reducing P53 accumulation. Biochem Biophys Res Commun 2008, 377:1025-1030.
33. Park S.A., Choi K.S., Bang J.H., Huh K., Kim S.U. Cisplatin-induced apoptotic cell death in mouse hybrid neurons is blocked by antioxidants through suppression of cisplatin-mediated accumulation of p53 but not of Fas/Fas ligand. J Neurochem 2000, 75:946-953.
34. Pfuhler S., Wolf H.U. Detection of DNA-crosslinking agents with the alkaline comet assay. Environ Mol Mutagen 1996, 27:196-201.
35. Podratz J.L., Knight A.M., Ta L.E., Staff N.P., Gass J.M., Genelin K., et al. Cisplatin induced mitochondrial DNA damage in dorsal root ganglion neurons. Neurobiol Dis 2011, 41:661-668.
36. Pravst I., Zmitek K., Zmitek J. Coenzyme Q10 contents in foods and fortification strategies. Crit Rev Food Sci Nutr 2010, 50:269-280.
37. Rahman I., Kode A., Biswas S.K. Assay for quantitative determination of glutathione and glutathione disulfide levels using enzymatic recycling method. Nat Protoc 2006, 1:3159-3165.
38. Roelofs R.I., Hrushesky W., Rogin J., Rosenberg L. Peripheral sensory neuropathy and cisplatin chemotherapy. Neurology 1984, 34:934-938.
39. Saito Y., Fukuhara A., Nishio K., Hayakawa M., Ogawa Y., Sakamoto H., et al. Characterization of cellular uptake and distribution of coenzyme Q10 and vitamin E in PC12 cells. J Nutr Biochem 2009, 20:350-357.
40. Salazar A.M., Sordo M., Ostrosky-Wegman P. Relationship between micronuclei formation and p53 induction. Mutat Res 2009, 672:124-128.
41. Serpeloni J.M., Barcelos G.R., Friedmann Angeli J.P., Mercadante A.Z., Lourdes Pires Bianchi M., Greggi Antunes L.M. Dietary carotenoid lutein protects against DNA damage and alterations of the redox status induced by cisplatin in human derived HepG2 cells. Toxicol In Vitro 2011, 26:288-294.
42. Shabani M., Nazeri M., Parsania S., Razavinasab M., Zangiabadi N., Esmaeilpour K., et al. Walnut consumption protects rats against cisplatin-induced neurotoxicity. Neurotoxicology 2012, 33:1314-1321.
43. Sikorska M., Borowy-Borowski H., Zurakowski B., Walker P.R. Derivatised alpha-tocopherol as a CoQ10 carrier in a novel water-soluble formulation. BioFactors 2003, 18:173-183.
44. Singh N.P., McCoy M.T., Tice R.R., Schneider E.L. A simple technique for quantitation of low levels of DNA damage in individual cells. Exp Cell Res 1988, 175:184-191.
45. Somayajulu-Nitu M., Sandhu J.K., Cohen J., Sikorska M., Sridhar T.S., Matei A., et al. Paraquat induces oxidative stress, neuronal loss in substantia nigra region and parkinsonism in adult rats: neuroprotection and amelioration of symptoms by water-soluble formulation of coenzyme Q10. BMC Neurosci 2009, 10:88.
46. Somayajulu M., McCarthy S., Hung M., Sikorska M., Borowy-Borowski H., Pandey S. Role of mitochondria in neuronal cell death induced by oxidative stress; neuroprotection by Coenzyme Q10. Neurobiol Dis 2005, 18:618-627.
47. Tice R.R., Agurell E., Anderson D., Burlinson B., Hartmann A., Kobayashi H., et al. Single cell gel/comet assay: guidelines for in vitro and in vivo genetic toxicology testing. Environ Mol Mutagen 2000, 35:206-221.
48. Tomaszewski A., Busselberg D. Cisplatin modulates voltage gated channel currents of dorsal root ganglion neurons of rats. Neurotoxicology 2007, 28:49-58.
49. Verstappen C.C., Postma T.J., Geldof A.A., Heimans J.J. Amifostine protects against chemotherapy-induced neurotoxicity: an in vitro investigation. Anticancer Res 2004, 24:2337-2341.
50. Wang D., Lippard S.J. Cellular processing of platinum anticancer drugs. Nat Rev Drug Discov 2005, 4:307-320.
51. Yang J., Duerksen-Hughes P. A new approach to identifying genotoxic carcinogens: p53 induction as an indicator of genotoxic damage. Carcinogenesis 1998, 19:1117-1125.
52. Yang L., Calingasan N.Y., Wille E.J., Cormier K., Smith K., Ferrante R.J., et al. Combination therapy with coenzyme Q10 and creatine produces additive neuroprotective effects in models of Parkinson's and Huntington's diseases. J Neurochem 2009, 109:1427-1439.
53. Yoo Y.E., Hong J.H., Hur K.C., Oh E.S., Chung J.M. Iron enhances NGF-induced neurite outgrowth in PC12 cells. Mol Cells 2004, 17:340-346.
54. Zhang K., Mack P., Wong K.P. Glutathione-related mechanisms in cellular resistance to anticancer drugs. Int J Oncol 1998, 12:871-882.